Laurianne Simard, MD (she/her/hers)

Université Laval
Québec, QC, Canada

PGY-4 Immunology and allergy

Presentation(s):

• 1109: Characteristics of SARS-CoV-2 infected Patients with Rheumatic Diseases on Rituximab: A Subanalysis of the COVID-19 Vaccine Booster in Immunocompromised Rheumatic Diseases (COVBIRD) Study

  Monday, October 27, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure(s): No financial relationships with ineligible companies to disclose